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The expression of a gene requires not only a normal coding sequence but also intact regulatory regions, which can
be located at large distances from the target genes, as demonstrated for an increasing number of developmental
genes. In previous mutation studies of the role of FOXL2 in blepharophimosis syndrome (BPES), we identified
intragenic mutations in 70% of our patients. Three translocation breakpoints upstream of FOXL2 in patients with
BPES suggested a position effect. Here, we identified novel microdeletions outside of FOXL2 in cases of sporadic
and familial BPES. Specifically, four rearrangements, with an overlap of 126 kb, are located 230 kb upstream of
FOXL2, telomeric to the reported translocation breakpoints. Moreover, the shortest region of deletion overlap
(SRO) contains several conserved nongenic sequences (CNGs) harboring putative transcription-factor binding sites
and representing potential long-range cis-regulatory elements. Interestingly, the human region orthologous to the
12-kb sequence deleted in the polled intersex syndrome in goat, which is an animal model for BPES, is contained
in this SRO, providing evidence of human-goat conservation of FOXL2 expression and of the mutational mechanism.
Surprisingly, in a fifth family with BPES, one rearrangement was found downstream of FOXL2. In addition, we
report nine novel rearrangements encompassing FOXL2 that range from partial gene deletions to submicroscopic
deletions. Overall, genomic rearrangements encompassing or outside of FOXL2 account for 16% of all molecular
defects found in our families with BPES. In summary, this is the first report of extragenic deletions in BPES,
providing further evidence of potential long-range cis-regulatory elements regulating FOXL2 expression. It con-
tributes to the enlarging group of developmental diseases caused by defective distant regulation of gene expression.
Finally, we demonstrate that CNGs are candidate regions for genomic rearrangements in developmental genes.
Introduction
The expression pattern of many developmental genes is
regulated at different levels. Usually, basal gene expres-
sion is controlled by the core promoter, located imme-
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diately upstream of the ORF. However, spatiotemporally
and quantitatively correct gene expression is often con-
trolled by long-range cis-acting regulatory elements as
distant as 1.1 Mb (Velagaleti et al. 2005). These elements
(enhancers, insulators, and locus-control regions) can be
located upstream or downstream of the transcription
unit of a gene. Interspecies comparative studies show a
strong evolutionary conservation of these elements,
which may reside in unrelated neighboring genes or in-
tergenic regions. Genomic rearrangements involving
such elements outside of a transcription unit can give
rise to human disease by a dissociation of the transcrip-
206 Am. J. Hum. Genet. 77:205–218, 2005
tion unit and its cis-acting regulatory elements, by an
alteration of the chromatin structure, or by both mech-
anisms (reviewed by Kleinjan and van Heyningen [2005]).
Recently, it was shown that heterozygous mutations
of the FOXL2 gene (MIM 605597), which encodes a
forkhead transcription factor, cause both types of ble-
pharophimosis-ptosis-epicanthus inversus syndrome
(BPES [MIM 110100]). BPES is a rare, autosomal dom-
inant developmental disorder characterized by an eyelid
malformation. Two subtypes have been identified; type
I is associated with premature ovarian failure (POF),
whereas type II is not (Zlotogora et al. 1983). It was
shown that haploinsufficiency of FOXL2 was caused
by intragenic mutations, in most cases, and by submi-
croscopic deletions encompassing FOXL2 and neigh-
boring genes, in two cases (De Baere et al. 2001, 2003).
A genotype-phenotype correlation was proposed mainly
on the basis of intragenic mutations distinguishing the
two BPES types at the molecular level (De Baere et al.
2003). Despite the ovarian phenotype in BPES, several
studies have indicated that mutations in FOXL2 do not
play a major role in causing idiopathic POF (De Baere
et al. 2001, 2002; Harris et al. 2002; Bodega et al.
2004).
A spatiotemporally restricted expression pattern of
the FOXL2 transcript and protein was demonstrated in
several species (human, mouse, and goat). It was shown
to be expressed in developing eyelids and in granulosa
cells of fetal and adult ovaries (Crisponi et al. 2001;
Cocquet et al. 2002, 2003). Recently, two studies pre-
senting homozygous knockout mice showed that gran-
ulosa cell function is crucial not only for oocyte growth
but also for ovarian maintenance, thus providing a mo-
lecular mechanism for POF in BPES in vivo (Schmidt
et al. 2004; Uda et al. 2004).
During the positional cloning of FOXL2, three bal-
anced translocations were characterized in patients with
a classic BPES phenotype. It was shown that the break-
points of these translocations disrupt two other genes
(BPESC1 and MRPS22), both devoid of pathogenic mu-
tations in other patients with BPES, suggesting a posi-
tion effect (De Baere et al. 2000; Praphanphoj et al.
2000; Crisponi et al. 2001, 2004).
Sequencing of the FOXL2 ORF, in combination with
FISH analysis with a probe encompassing the FOXL2
gene, revealed mutations in !70% of patients with BPES
(De Baere et al. 2001, 2003). Here, we applied a novel
mutation-detection strategy consisting of multiplex li-
gation-dependent probe amplification (MLPA), geno-
typing with 160 microsatellites and SNPs, and com-
prehensive FISH analysis. This approach led to the
identification of nine novel deletions encompassing
FOXL2, which ranged from partial and total gene de-
letions to microdeletions and submicroscopic deletions.
Notably, five novel deletions were found either up-
stream or downstream of the transcription unit of
FOXL2. These genic and extragenic (micro)deletions
account for 11% and 5%, respectively, of all molecular
defects found in our cohort with BPES. Finally, we re-
port the first case of germline mosaicism in a family
with BPES that is confirmed at the molecular level.
Material and Methods
Patients and Diagnostic Criteria
The 37 consenting probands with BPES who were
included in this study presented with blepharophimo-
sis, ptosis, epicanthus inversus, and telecanthus. The
clinical diagnosis was given by a clinical geneticist or an
ophthalmologist. When possible, karyotyping was per-
formed in the referring laboratory. The karyotype was
not confirmed by us. In each proband, intragenic mu-
tations were excluded by sequencing of the FOXL2
ORF, as described by De Baere et al. (2001).
Custom-Made MLPA
MLPA permits relative quantification of changes in
copy number of specific chromosomal sequences (Schou-
ten et al. 2002). A custom-made deletion-detection kit
for FOXL2 was developed by MRC-Holland (P054
FOXL2) and contains three different probes for FOXL2
(FOXL2-D01, FOXL2-D02, and FOXL2-D03), four
probes for the ATR gene (located at 3q22-24), and
probes for other genes (TWIST, FOXC1, PITX2,
FOXC2, and OA1). Probe FOXL2-D01 is located in
the forkhead domain (c.252–351; g.489–588), probe
FOXL2-D02 is between the forkhead domain and the
polyalanine tract (c.575–641; g.812–878), and probe
FOXL2-D03 is downstream of the polyalanine tract
(c.1053–1113; g.1290–1350). MLPA was performed in
accordance with the manufacturer’s instructions.
FISH
A genomic BAC contig of region 3q23 was obtained
from the National Center for Biotechnology Informa-
tion (NCBI) database. BACs were obtained from The
Wellcome Trust Sanger Institute and BACPAC Resources
Center. PACs and cosmids had been previously obtained
from the UK–Medical Research Council and were
mapped by FISH (De Baere et al. 1999). BAC, PAC, and
cosmid DNA was prepared and labeled with the use of
standard conditions. FISH analysis was performed as
described by De Baere et al. (1999).
Microsatellite Analysis
Fifteen polymorphic microsatellites (with prefix “D3S”)
were selected from the NCBI on the basis of location
and heterozygosity. Primer sequences of markers with
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Table 1
Primer Sequences of Novel Microsatellites and
SNaPshot Analysis
The table is available in its entirety in the online edition
of The American Journal of Human Genetics.
prefixes “VY” and “NU” were obtained from Udar et
al. (2003). A third series of microsatellites (Tel2 and
markers with prefix “EDB”) was developed by a manual
search for repeats in the BAC sequences derived from
NCBI. For a fourth series (with prefix “DB”), the dif-
ferent BAC sequences were analyzed using the Find Sim-
ple Repeats software, which selects repetitive sequences
that are expected to have a very high degree of poly-
morphism. The search was confined to sequences pre-
senting repetitions with a maximum of 4 nt and having
a total length of at least 12 nt. Sequences with a score
30 were selected for primer design. Primer sequences
are given in table 1. Characterization of the polymorphic
nature of the known and novel microsatellites was per-
formed in a white population by use of an M13-system
described by Schuelke (2000). For allele sizing, aliquots
of PCR reaction were mixed with ROX-500 or ROX-
1000 size standard (Applied Biosystems) and formamide
and were separated on an ABI PRISM 3100 Genetic
Analyzer (Applied Biosystems). Fragment sizing was per-
formed automatically using GeneScan version 3.7. The
different microsatellite alleles were numbered consecu-
tively, in order of increasing size. The numbering is dif-
ferent for each family.
SNaPshot Analysis
Twenty-seven SNP loci were selected from the Inter-
national HapMap Project database, and amplification
primers were designed so that PCR products of ∼300
bp were obtained. Typing primers were designed to an-
neal to the target DNA flanking the 3′ end of the SNP.
A standard PCR reaction was performed, followed by
exonuclease I and shrimp alkaline phosphatase (SAP)
treatment (Amersham). A single-nucleotide primer ex-
tension reaction was performed using an ABI PRISM
SNaPshot Multiplex kit (Applied Biosystems), in accor-
dance with the manufacturer’s instructions. After SAP
treatment, products were separated on an ABI PRISM
3100 Genetic Analyzer (Applied Biosystems) and were
analyzed with GeneScan version 3.7. Numbers were as-
signed to alleles as follows: Ap 1, Cp 2, Gp 3, and
Tp 4.
To assess the degree of germline mosaicism in an
unaffected male, quantitative SNaPshot analysis was
performed as described by Ma´tya´s et al. (2002). For
normalization, genomic samples from four unrelated in-
dividuals who have an identical SNP haplotype as that
of the test sample were used as controls.
Long-Range PCR
For long-range PCR, the Expand Long Template PCR
System (Roche) was used. A master mix of 50 ml con-
tained 300 ng of genomic DNA, 0.5 mM of each primer,
5 ml of Expand Long Template PCR buffer 3 (containing
10 # PCR buffer and 27.5 mM MgCl2), 3.75 U of
Expand Long Template enzyme mix (containing Taq
DNA polymerase and Tgo DNA polymerase), 500 mM
of each dNTP, and 3 mM additional MgCl2. Cycling
conditions included an initial denaturation cycle at 94C
for 2 min, followed by 10 cycles at 94C for 20 s, 65C
for 30 s, and 68C for 12 min; 25 cycles at 94C for 30
s and 65C for 30 s and elongation for 12 min plus 20
s for each successive cycle; and a final extension at 72C
for 7 min.
Construction of a High-Resolution Physical Map
Covering Microdeletions
First, we generated a sequence contig of 16 over-
lapping RPCI-11 BAC clones that span ∼1.8 Mb sur-
rounding FOXL2 by a search of GenBank (NCBI). The
polymorphic microsatellites selected from NCBI were
positioned on this BAC contig by use of the reference
numbering of build 34, version 3 (“the golden path”),
and by use of BLAST (NCBI). The localization of the
anonymous microsatellites and SNPs was verified by
BLAST searches against the BAC sequences. The exact
PAC and cosmid localization was determined by BLAST
after PAC and cosmid end sequencing, in accordance
with standard protocol. Finally, the different known and
unassigned genes that are located in this region were
added to the map according to NCBI data.
Comparative Sequence Analysis
To identify conserved nongenic sequences (CNGs),
comparative sequence analysis of the regions of interest
was performed using the University of California–Santa
Cruz (UCSC) Genome Browser. The UCSC Multiz Align-
ments and Conservation track contains a measure of
evolutionary conservation in human, chimp, mouse, rat,
dog, chicken, pufferfish, and zebrafish based on a phy-
logenetic hidden Markov model (phastCons). The over-
all conservation score across all species, as well as pair-
wise alignments of each species aligned to the human
genome, were retrieved, and gapped alignments were
included. The length of the alignment is based on the
lengths of gaps in the human sequence at those alignment
positions, relative to the longest nonhuman sequence.
Alignments are based on the following genome assem-
blies: human, May 2004 (hg17); chimp, November 2003
(panTro1); mouse, May 2004 (mm5); rat, June 2003
(rn3); dog, July 2004 (canFam1); chicken, February
2004 (galGal2); Fugu, August 2002 (fr1); and zebrafish,
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Figure 1 A, Physical map of a 1.8-Mb region flanking FOXL2 that shows the position of the BACs, PACs, cosmids, microsatellites, and
SNPs that were used for identification and delineation of the deletions. The map is drawn to scale; the size equivalent to 50 kb is given at the
bottom left corner. The location of FOXL2 is indicated by a vertical black line. The top line represents the localization of SNPs, and the second
line contains the known and anonymous microsatellites used in this study. In the third line, the location of the genes in this region is shown,
whereas the BACs, PACs, and cosmids used for FISH are shown below the line. The lower part of A is an overview of all deletions identified
in this study, except one. Every line represents a patient or family in whom a deletion was found. The dashed red line shows the maximal
extent of the deletion. The first 10 lines represent the deletions that encompass FOXL2. The deletion identified in BPES11 is not shown, since
the extent of the deletion could not be determined because of a lack of material for FISH and microsatellite analysis. The second group represents
the five extragenic deletions (four upstream and one downstream). Clinical details and molecular data on the patients with deletions are shown
in table 2. In a box at the bottom right, a detailed view of the SRO of the four upstream extragenic deletions is shown. The position of FOXL2
is marked by a vertical dashed black line, and the SRO is shown by the dashed red line. The positions of the known three translocation
breakpoints at 3q23 in BPES and of the orthologue of the PIS locus are indicated by vertical arrows. B and C, UCSC Genome Browser map
of the SRO of the four upstream extragenic rearrangements in families BPES12, BPES13, BPES14, and BPES15. CNGs are highlighted at the
bottom with red boxes. Their names, based on our arbitrary numbering, are given below the boxes. Details on all CNGs can be found in table
4. The CNGs shown in B are evolutionarily conserved up to chicken. C represents a more detailed view of CNG3–CNG7. CNG3–CNG5 are
conserved up to zebrafish and/or pufferfish. They all represent potential cis-regulatory elements of the FOXL2 region. D, UCSC Genome Browser
map of the sequence contained in the downstream extragenic rearrangement in family BPES16. Five CNGs are indicated in this 3′ SRO, of
which several are conserved up to zebrafish and/or pufferfish (CNG14, CNG18, and CNG22–CNG24).
November 2003 (danRer1). Our selection criteria in-
cluded conservation at least up to chicken, pufferfish,
and/or zebrafish, independent of alignment length, per-
centage of conservation, and presence of gaps.
The respective sequences of the selected elements and
their corresponding mouse sequences were retrieved
through the UCSC Genome Browser. Apart from these
sequences, an available 48-kb goat sequence from the
polled intersex syndrome (PIS) locus (GenBank accession
number AF404302) was retrieved for human-goat com-
parison with the use of mVista. A pairwise alignment
was performed between human and mouse, human and
goat, human and chicken, human and pufferfish, and
human and zebrafish by use of ClustalW. To exclude the
coding potential of all putative CNGs, the human se-
quence of the conserved region was compared with all
available EST and protein sequences in GenBank, as well
as with all gene predictions for the selected region avail-
able from the UCSC Genome Browser and the Biomax
Human Genome Database (blastn, blastx, tblastx, and
nrprot). In addition, sequences were scanned for repet-
itive elements using RepeatMasker. Sequences that did
not show significant similarity to known proteins, genes
and/or transcripts, or transposable elements were se-
lected as CNGs. These were searched against the Trans-
fac database (version 8.3) of known vertebrate cis-acting
regulatory DNA elements and trans-acting factors by use
of the Match tool included in that database (Matys et
al. 2003). Only highly significant matches with tran-
scription-factor binding sites were considered, by use of
the built-in “minimize false positive matches” setting.
Results and Discussion
The mutation detection rate of !70% in previous mu-
tation studies of FOXL2 in BPES could be explained by
clinical misdiagnosis; the sensitivity of the strategy used,
which might not allow detection of changes in gene copy
number or in distant sequences outside of the transcrip-
tion unit of FOXL2 (De Baere et al. 2001, 2003); or
the presence of a second BPES locus, although there is
no evidence to support the existence of a second locus.
Here, we developed a novel combined approach con-
sisting of (1) custom-made MLPA for detection of
changes in gene copy number of FOXL2 and other
genes; (2) a genotyping panel, comprising 15 known and
32 anonymous microsatellites and 26 SNPs; and (3)
comprehensive FISH analysis whenever possible.
Genomic Rearrangements Encompassing FOXL2
A clue to subtle FOXL2 deletions was found in similar
observations for FOXC1, which encodes a forkhead
transcription factor associated with ocular anterior seg-
ment dysgenesis (IRID1 [MIM 601631]). Irrespective of
whether the gene is duplicated or deleted, a nearly iden-
tical ocular phenotype is observed, showing that exact
gene dosage of FOXC1 is critical for normal eye devel-
opment (Lehmann et al. 2003).
Our approach allowed identification of 11 deletions
encompassing FOXL2, of which 9 are novel. These de-
letions contribute to 11% (11/100) of all molecular de-
fects found in our series of patients with BPES and are
found in 30% (11/37) of mutation-negative patients.
They occur in sporadic cases and familial cases and are
absent in all unaffected family members analyzed. A
graphical overview of these deletions is given in figure
1A. Clinical data for the 11 families and molecular de-
tails on the deletions are summarized in table 2.
The rearrangements include one partial FOXL2 de-
letion (in BPES10), an 8-kb deletion removing the whole
FOXL2 ORF (in BPES9), two microdeletions of up to
420 kb, encompassing FOXL2 and neighboring genes
(in BPES7 and BPES8), four submicroscopic deletions
(in BPES2, BPES4, BPES5, and BPES6), and two micro-
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Figure 3 Schematic diagram of FOXL2 gene and protein, elec-
tropherogram of MLPA products, sequence electropherogram of the
deletion junction fragment, and nucleotide sequence of the breakpoint
junctions. The legend is available in its entirety in the online edition
of The American Journal of Human Genetics.
Figure 2 Pedigrees with BPES and a rearrangement encompassing FOXL2 or located outside of the transcription unit. Intragenic FOXL2
mutations were excluded by sequencing of the ORF in all patients. MLPA was performed to assess changes in gene copy number, and haplotypes
are based on microsatellite or SNP analysis. An exclamation mark (!) indicates hemizygosity of an allele. BPES9, Microsatellite analysis in two
generations of this French family showed apparent linkage to FOXL2. However, no intragenic FOXL2 mutation was found in affected members.
MLPA analysis revealed a total gene deletion of FOXL2. Long-range PCR revealed the breakpoints of an 8-kb deletion (fig. 3). The occurrence
of secondary amenorrhea in II:1 suggests this family has type I BPES. In addition, III:2 has a heart malformation in association with BPES.
BPES16, In this family, two affected half-sisters (II:1 and II:3) have BPES, whereas their father (I:2) is clinically unaffected, suggesting germline
mosaicism. FISH and microsatellite analysis revealed an extragenic deletion of 188 kb located 3′ of FOXL2 in the half-sisters. Microsatellite
analysis showed an apparent absence of this deletion in their father. However, quantitative studies revealed somatic mosaicism for this deletion
in 5% of DNA from his leucocytes and 10% of DNA from his sperm cells, confirming germline mosaicism at the molecular level (table 3).
BPES12, Upstream microdeletion in a 14-year-old male with sporadic BPES and additional features. MLPA showed normal FOXL2 and ATR
gene copy numbers, whereas several microsatellites at a distance from FOXL2 were hemizygous, indicating a deletion outside of the transcription
unit. The centromeric breakpoint of the deletion is located in a 69-kb interval between microsatellites EDB14 and DB17; at the telomeric side,
the deletion extends beyond the borders of the physical map in figure 1A, but does not contain D3S1309. The deletion encompasses at least
several known and unknown genes (LOC389152, BPESC1, MRPS22, COPB2, RBP2, ACTGP1, RBP1, NMNAT3, and CLSTN2) and extends
beyond 1.9 Mb. The contribution of each gene to the psychomotor retardation and other associated features in this patient is unclear. BPES13,
Upstream microdeletion of maternal origin in a 2-year-old female with sporadic BPES who had normal psychomotor development and micro-
cephaly. The deletion spans 567 kb at the most; the centromeric breakpoint is located between microsatellites EDB14 and DB16, and the
telomeric breakpoint is between markers DB19 and D3S2435. The deletion covers part of BPESC1, MRPS22, COPB2, RBP2, ACTGP1, RBP1,
and NMNAT3. BPES14, Microdeletion of ∼200 kb 5′ of FOXL2 in two affected females, I:2 and II:1, of a two-generation family with type
II BPES. FISH analysis with probes RP11-548O1, RP11-306L14, RP11-319G6, Pac204O7, and Cos11L10 showed normal hybridization signals
on both chromosomes 3, whereas RP11-657M13, Cos12P5, and Pac208L5 were deleted. One normal and one lighter signal were seen with
RP11-219D15 and PAC169C10, confirming that the deletion breakpoints are located in these probes. The centromeric breakpoint of the deletion
is located between DB16 and D3S3586, and the telomeric breakpoint is between EDB2′ and DB5. BPES15, Extragenic microdeletion found
in a five-generation Belgian family with BPES type II, previously linked to 3q23 (Messiaen et al. 1996). This 126-kb microdeletion is the smallest
one upstream of FOXL2 and delineates the SRO of the different microdeletions located at this side of FOXL2 (detailed view in fig. 1A). FISH
probes RP11-657M13 and PAC208L5 showed one lighter and one normal hybridization signal, thus indicating the borders of the deletion.
Analysis with adjacent probes showed two normal signals. The hemizygous microsatellites indicate that the centromeric breakpoint is located
between rs10935309 and rs955084 and the telomeric breakpoint is between rs6802174 and rs4894405 (fig. 1A).
scopic deletions (in BPES1 and BPES3) (fig. 1A and table
2). In patient BPES11, MLPA analysis revealed a total
FOXL2 deletion; however, the extent could not be de-
termined because of the lack of appropriate patient and
parental material. The deletion breakpoints are scat-
tered, suggesting lack of a deletion-prone region and
nonhomologous end joining as the common causal
mechanism (Shaw and Lupski 2004), which is supported
by characterization of the junction fragment of an 8-kb
deletion in family BPES9 with BPES type I (fig. 2 and
fig. 3C and 3D). Attempts to characterize the junction
fragments by long-range PCR failed for the other subtle
deletions presented in this study.
In the three families with BPES in which several af-
fected members are heterozygous for a total gene dele-
tion (BPES9), a microdeletion (BPES7), or a submicro-
scopic deletion (BPES5), microsatellite analysis showed
similar extents of the deletion in the affected family
members of different generations, suggesting stability
during meiosis (fig. 2 and fig. 4).
Previously, two submicroscopic deletions of 13.8 Mb
and 3.2 Mb were found in patient BPES2 and the pro-
band of BPES5, respectively, both of whom had psy-
chomotor retardation and microcephaly as associated
features. These findings led to a preliminary genotype-
phenotype correlation (De Baere et al. 2001, 2003).
Here, we identified a submicroscopic deletion of 13.5
Mb in a young woman with sporadic BPES (BPES4) who
has microcephaly but apparently normal psychomotor
development, suggesting that the extent of the deletion
is not necessarily in linear correlation with the occur-
rence of developmental delay (table 2 and fig. 1A). In a
recent study, it was postulated that mental retardation
is associated with a heterozygous deletion of the Seckel-
associated ATR gene located 3.6 Mb telomeric to FOXL2
(Gille et al. 2003). In our series of patients, however,
there was no consistent correlation between ATR hap-
loinsufficiency and developmental delay, as seen in pa-
tient BPES4 and family BPES5 (table 2).
In addition, in 9 of 11 patients, the BPES type could
not be determined (for prepubertal females or males with
sporadic BPES). However, in the two families for which
it was possible to assess the BPES type (BPES9 and
BPES11), the deletion was found to lead to BPES and
POF (type I), which is in agreement with previous ge-
notype-phenotype correlations between heterozygous in-
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Figure 4 Haplotypes of families BPES5 and BPES7, in which
affected members carry a deletion encompassing FOXL2, illustrating
the stability of deletions in the different generations. The legend is
available in its entirety in the online edition of The American Journal
of Human Genetics.
Table 3
Results of Quantitative SNaPshot Analysis with SNPs
rs6773514, rs9289566, and rs9879784
The table is available in its entirety in the online edition
of The American Journal of Human Genetics.
tragenic mutations leading to a FOXL2 null allele and
BPES type I (De Baere et al. 2003). Because of the small
sample size, this hypothesis needs to be evaluated in
additional studies of patients carrying (micro)deletions.
To allow reliable genotype-phenotype correlations for
psychomotor development and POF risk, an accurate
delineation of deletions is a prerequisite.
In some informative families, it was possible to de-
termine the parental origin of the deletion, but no par-
ent-of-origin effect was observed (maternal :paternal
deletion ratio was 4:3) (table 2). Thus, BPES does not
belong to the group of conditions in which sex-depen-
dent mechanisms may play a role in the origin of the
underlying genomic rearrangement (e.g., Charcot-Marie
Tooth 1A and hereditary neuropathy with liability to
pressure palsies) (Lopes et al. 1997).
Genomic Rearrangements Outside of the Transcription
Unit of FOXL2
A complex regulation of gene expression has been
suggested for several forkhead transcription factors
by the occurrence of chromosomal rearrangements
(translocations) upstream (FOXC1) and downstream
(FOXC2) of their respective transcription units (Davies
et al. 1999; Fang et al. 2000). For the FOXL2 locus,
specifically, three translocation breakpoints located 170
kb upstream of the disease gene cause exactly the same
phenotype as loss-of-function mutations (De Baere et al.
2000; Praphanphoj et al. 2000; Crisponi et al. 2001,
2004).
Here, we report five novel deletions mapping up-
stream and downstream of the transcription unit of
FOXL2 in patients with BPES with a phenotype iden-
tical to that caused by intragenic mutations. The pres-
ence of an intact transcription unit (coding sequence and
copy number) was confirmed by sequencing and MLPA
in all affected patients. The extragenic genomic rear-
rangements contribute to 5% (5/100) of all the molec-
ular defects identified in our series of patients with BPES
and are found in 14% (5/37) of our mutation-negative
patients with BPES. They are found in patients with
sporadic BPES and patients with familial BPES and are
absent in unaffected individuals. An overview of the lo-
cation and extent of these rearrangements is given in
figure 1A, and relevant clinical data for the patients are
given in table 2.
First, we identified a genomic rearrangement—pre-
sumed to be a microdeletion of ∼188 kb—downstream
of FOXL2 in family BPES16, in which two affected half-
sisters have typical BPES, whereas their father is clini-
cally unaffected, which is suggestive of germline mosa-
icism (fig. 2 and table 2). To confirm paternal germ-
line mosaicism at a molecular level, quantitative SNaP-
shot analysis was performed for three informative
SNPs located in the deletion (rs9879784, rs9289566,
and rs6773514) (table 3). We estimated that ∼10% of
the paternal germ cells and 5% of somatic peripheral
blood lymphocytes carry the deletion (table 3). The es-
timated recurrence risk in this family is 10%, being sig-
nificantly higher than the risk of a de novo event (!1%).
This is the first case of germline mosaicism in BPES that
is documented at the molecular level. This study indi-
cates that this is an important issue to be considered in
genetic counseling.
Second, we identified four overlapping microdele-
tions, which ranged from 126 kb to 1.9 Mb, upstream
of the transcription unit of FOXL2. These extragenic
deletions were found in two patients with a sporadic
form of BPES (BPES12 and BPES13) and in two families
(BPES14 and BPES15) (fig. 1A and fig. 2). In two of
these families, assessment of the BPES type was possible;
the absence of female infertility or overt POF in affected
females of families BPES14 and BPES15 suggests that
these 5′-located microdeletions do not significantly per-
turb ovarian expression of FOXL2 and thus lead to
BPES type II.
Of the two affected half-sisters in family BPES16 with
the downstream microdeletion, II:3 has typical BPES
with apparently normal psychomotor development at
age 4 years, whereas II:1 has BPES and also presents
moderate learning difficulties that were apparent from
age 6 years, intrauterine and postnatal growth retar-
dation, and microcephaly (fig. 2 and table 2). She was
born at a gestational age of 32 weeks because of pre-
eclampsia. There is no indication of a different extent
of the deletion in the two patients. Another patient
(BPES12), heterozygous for a 1.9-Mb upstream deletion,
has BPES and presents additional features, including mi-
crocephaly, intrauterine and postnatal growth retarda-
tion, and a ventricular septum defect (fig. 2 and table
2). These additional features might represent a contig-
uous gene syndrome that can be explained by the extent
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Table 4
Details of CNGs Found in the Respective SROs of the
Upstream and Downstream Genomic Rearrangements
The table is available in its entirety in the online edition
of The American Journal of Human Genetics.
of the deletion. In the other three families (BPES13,
BPES14, and BPES15), no associated features were pre-
sent. For the extragenic rearrangements, we can con-
clude that there is no association with psychomotor re-
tardation and that there are as yet no arguments for a
correlation with POF risk.
In familial cases BPES14, BPES15, and BPES16, mi-
crosatellite and FISH analysis indicated that the extent
of the respective extragenic deletion is equal in each gen-
eration, suggesting stability during meiosis in these fam-
ilies (fig. 2). These clinical and molecular observations
underscore the value of using complementary tools to
delineate the extent of microdeletions together with as-
sessment of the gene copy number of FOXL2.
The shortest region of deletion overlap (SRO) of the
5′ microdeletions involves a 126-kb region. Interestingly,
it contains the human orthologue of the PIS locus in the
goat. PIS, characterized by polledness (absence of horns)
and XX intersexuality, is an animal model for BPES.
Pailhoux et al. (2001) showed that it was caused by a
12-kb deletion located 280 kb upstream of FOXL2. This
deletion does not contain any coding sequences and af-
fects transcription of at least two genes in the PIS goat:
the noncoding PISRT1 and FOXL2, located at 20 kb
and 280 kb from the deletion, respectively. It was sug-
gested that the PIS locus contains elements involved in
long-range cis-regulation of goat FOXL2 (Pailhoux et
al. 2001). Our current study lends further support to
this hypothesis.
Moreover, this SRO is located telomeric to three
known translocation breakpoints in BPES (fig. 1A). Cris-
poni et al. (2004) noted that these breakpoints are all
located in intron 6 of the MRPS22 gene. Using human-
mouse comparative sequence analysis, they showed the
presence of three highly conserved sequence blocks up-
stream of the most distal breakpoint, in introns 6, 11,
and 12 of MRPS22. The PIS locus was shown to be
located in the conserved sequence block in intron 11 of
MRPS22. It was postulated that these conserved se-
quence blocks are candidate regions that might function
as distant enhancers or have an influence on higher-order
chromatin structure, both of which affect long-range cis-
regulation of FOXL2 expression.
CNGs in the SRO of Extragenic Rearrangements
Recent experimental approaches demonstrated that a
fraction of CNGs in the genome act as cis-transcriptional
regulators, although little is known about their function
(Dermitzakis et al. 2002, 2003). Furthermore, it has been
shown that conserved sequences are clustered around
developmental genes and function as regulatory elements
that affect embryonic development (Bejerano et al. 2004;
Plessy et al. 2005). In addition, genomic variation in
CNGs is presumed to be associated with phenotypic
variability and even with human monogenic conditions
(reviewed by Dermitzakis et al. [2005]). To identify po-
tential CNGs, a comparative sequence analysis was un-
dertaken in the SRO of the extragenic deletions. We
made use of publicly available, gapped and ungapped
alignments of the UCSC Genome Browser. Although a
human-mouse alignment is generally used, we made a
selection of conserved sequences across more distant spe-
cies to enhance the functional significance of the selected
CNGs. We performed human-chicken, human-puffer-
fish, human-zebrafish, and human-goat comparisons
(the latter only for an available 48-kb goat sequence
[GenBank accession number AF404302]). In the two
regions of interest, we identified 25 putative CNGs com-
mon to human and chicken, pufferfish, and/or zebrafish
and 1 common to human and goat. Seventeen of those
were eventually selected as CNGs, after we filtered for
coding and transposable elements (table 4). Some of
them (CNG3–CNG5) are conserved up to pufferfish or
zebrafish, strongly suggesting that they function as a
regulatory element (table 4). CNG3–CNG7 are all con-
tained in the human orthologue of the PIS locus. These
CNGs were found to be located in the 9-kb conserved
sequence block previously described by Crisponi et al.
(2004).
Analysis of these sequences with a Transfac database
revealed several interesting putative transcription-factor
binding sites for FOXP3 in CNG5 and CNG9; for HNF-
1 in CNG3, CNG9, CNG22, and CNG24; for HNF-4
in CNG1 and CNG2; and for embryonic gonadal reg-
ulator SOX9 in CNG3. Interestingly, a regulatory link
between SOX9 and the PIS locus has already been sug-
gested by Nikic and Vaiman (2004). We found that a
binding site for FOXL1 (ATTCAATAAAGAAGTA),
previously identified by Crisponi et al. (2004) in the 9-
kb conserved sequence block, was situated in CNG3.
The conserved nature of the elements located in the hu-
man orthologue of the PIS locus, together with the pre-
diction of potentially relevant binding sites, provide
arguments that they are cis-acting elements (e.g., an en-
hancer) regulating correct spatiotemporal FOXL2 ex-
pression during embryonic development.
It is nearly impossible to obtain human samples that
would allow meaningful analysis of regulation of
FOXL2 expression in developing eyelids and ovary. Such
analysis currently relies on genotype-phenotype corre-
lations of genomic rearrangements and BPES, compar-
ative sequence analysis, and experimental validation—
for instance, in animal models. In the two families in
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which the BPES type could be assessed, BPES14 and
BPES15, we found that the 5′ extragenic rearrangements
led to BPES type II. This “mild” phenotype can be ex-
plained either (1) by a selective regulation of craniofacial
FOXL2 expression by the 5′ distant elements or (2) by
regulation of both craniofacial and ovarian expression
but with the absence of an ovarian phenotype in the case
of a heterozygous deletion. The latter situation would
be identical to the regulation of FOXL2 expression in
the goat, in which both the craniofacial and ovarian
expression appear to be regulated by the PIS locus, but
in which phenotypic expression of polledness and XX
intersexuality depend on the heterozygous and homo-
zygous states of the deletion, respectively.
There are other diseases known to be caused by ge-
nomic rearrangements lying at considerable distances
from the disease gene and leading to phenotypes iden-
tical to those resulting from intragenic mutations. How-
ever, the majority is caused by chromosomal rearrange-
ments (translocations), and only a minority results from
deletions presumably affecting a regulatory element. The
first reported example was that of the locus of control
region (LCR) of the b-globin gene cluster. Translocation
breakpoints and deletions in this conserved element
cause autosomal recessive b-thalassemia due to silencing
of the b-globin gene, which maps 50 kb downstream of
the LCR (Driscoll et al. 1989). A hotspot for microde-
letions has been identified, in patients with X-linked
deafness type 3, that is 900 kb proximal to the POU3F4
disease gene. The 8-kb SRO of these deletions contains
a 2-kb sequence that is 80% conserved between human
and mouse (de Kok et al. 1996). More recently, the au-
tosomal recessive van Buchem disease was found to be
caused by a homozygous deletion that is 52 kb down-
stream of the disease gene SOST and contains two CNGs
(Balemans et al. 2002). Similarly, the upstream and
downstream genomic rearrangements described here dis-
sociate putative regulatory CNGs from their target gene
FOXL2 and lead to BPES, one of the first autosomal
dominant conditions for which this mechanism has been
demonstrated.
Our approach led to the identification of a molecular
defect in 16 (43%) of 37 mutation-negative patients with
BPES analyzed in this study. The lack of a sequence
variation or a rearrangement in 21 patients, representing
17% (21/121) of the total patient group, might be ex-
plained by the fact that assessment of the four diagnostic
criteria of BPES was done by different clinicians. In ad-
dition, the current strategy does not allow for detection
of inversions and subtle extragenic rearrangements, such
as deletions, duplications, and point mutations in reg-
ulatory elements. The latter mutational mechanism was
demonstrated in autosomal dominant preaxial polydac-
tyly syndrome in humans, for which four different path-
ogenic point mutations were found in a regulatory ele-
ment of 750 bp named “ZRS,” apparently regulating
expression of SHH that maps 1 Mb away (Lettice et al.
2003).
General Conclusions
In summary, this is the first study, to our knowledge,
to show that deletions mapping downstream and up-
stream of the FOXL2 transcription unit cause BPES.
Several potential upstream and downstream cis-acting
regulatory elements were identified by delineation of
these genomic rearrangements and by comparative gen-
omics. The identification of the upstream deletions con-
taining the human orthologue of the PIS locus in four
patients with BPES provides evidence of human-goat
conservation of the regulation of FOXL2 expression and
of the mutational mechanism. This study provides in-
sight into the regulation of expression of FOXL2, one
of the earliest markers of ovarian development. More
generally, it contributes to the enlarging group of human
developmental diseases caused by defective long-range
regulation of gene expression. It further demonstrates
one of the functions of conserved noncoding regions—
that is, to act as a cis-regulatory element. Finally, our
results emphasize that CNGs may be candidate regions
for harboring genomic rearrangements in monogenic de-
velopmental disorders.
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